LIVAZO 4MG 28 TAB

LIVAZO 4 mg Tablets (28 tablets)Active Ingredient: Pitavastatin Calcium (equivalent to Pitavastatin 4 mg)Therapeutic Class: Lipid-Lowering Agent – HMG-CoA Reductase Inhibitor (Statin)Indications: LIVAZO is indicated for: Treatment of primary hyperlipidemia and mixed dyslipidemia Reducing elevated total cholesterol, LDL-C (low-density lipoprotein cholesterol), and triglycerides Increasing HDL-C (high-density lipoprotein cholesterol) Reducing cardiovascular risk in patients with risk factors such as type 2 diabetes or existing coronary heart disease Mechanism of Action: Pitavastatin inhibits HMG-CoA reductase, the key enzyme in hepatic cholesterol biosynthesis. This results in reduced cholesterol production and increased clearance of LDL cholesterol from the bloodstream.Dosage and Administration: Recommended starting dose: 1–2 mg once daily, with or without food The dose may be adjusted up to a maximum of 4 mg/day depending on response and tolerance Monitor lipid levels periodically Warnings and Precautions: Contraindicated in active liver disease and during pregnancy or breastfeeding Use with caution in patients with renal impairment, history of muscle disorders, or high alcohol intake Monitor liver enzymes and creatine kinase (CK) if muscle symptoms occur Side Effects: Common: myalgia, back pain, constipation, diarrhea, headache Rare but serious: rhabdomyolysis, liver enzyme elevations Storage: Store below 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.